ArticleTranslational gastroenterology and hepatology2026
Non-exposure omental sealing endoscopic full-thickness resection (NEOS-EFTR) with sentinel node navigation surgery for early gastric cancer: a case series.
Article in Translational gastroenterology and hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06788548 (Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer: A Multicenter Randomized Controlled Trial Study
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Various non-exposurelaparoscopic and endoscopic cooperative surgery (NE-LECS) with sentinel node navigation surgery (SNNS) have been proposed for patients with early gastric cancer (EGC) exceeding the absolute indications for endoscopic submucosal dissection (ESD). However, the specific technical aspects of NE-LECS with SNNS require further clarification. This study proposes and evaluates a novel non-exposure omental sealing endoscopic full-thickness resection (NEOS-EFTR) with SNNS for EGC. Case Description: This study included 5 patients who underwent NEOS-EFTR with SNNS between July 2025 and September 2025. Clinical data and treatment outcomes were collected and analyzed. The mean tumor size was 2.7 cm (range: 2.1-3.6 cm), with an R0 resection achieved in all cases. SNNS were successfully performed in every patient. The mean operation time was 155 minutes (range: 140-185 minutes), and the mean postoperative hospital stay was 5.4 days (range: 4-9 days). No complications of grade I or above (Clavien-Dindo ≥ I) were recorded. During a mean follow-up of 3.4 months (range: 3-4), there was no evidence of tumor recurrence or metastasis, though this reflects only short-term observation given the limited follow-up duration. Although gastric emptying was transiently prolonged at the 1-week assessment, it returned to near-normal levels by 3 months postoperatively. Patient reported quality of life and functional scores remained well-preserved throughout. This study was registered with ClinicalTrials.gov (NCT06788548). Conclusions: NEOS-EFTR with SNNS offers a promising alternative for managing EGC that extends beyond the absolute indications for ESD, presenting certain advantages over conventional NE-LECS. The preliminary efficacy and safety profiles observed require further validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.